216 related articles for article (PubMed ID: 22396110)
1. Guideline-based antibiotics and mortality in healthcare-associated pneumonia.
Madaras-Kelly KJ; Remington RE; Sloan KL; Fan VS
J Gen Intern Med; 2012 Jul; 27(7):845-52. PubMed ID: 22396110
[TBL] [Abstract][Full Text] [Related]
2. Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome.
Micek ST; Reichley RM; Kollef MH
Medicine (Baltimore); 2011 Nov; 90(6):390-395. PubMed ID: 22033455
[TBL] [Abstract][Full Text] [Related]
3. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.
Attridge RT; Frei CR; Restrepo MI; Lawson KA; Ryan L; Pugh MJ; Anzueto A; Mortensen EM
Eur Respir J; 2011 Oct; 38(4):878-87. PubMed ID: 21436359
[TBL] [Abstract][Full Text] [Related]
4. Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.
Attridge RT; Frei CR; Pugh MJ; Lawson KA; Ryan L; Anzueto A; Metersky ML; Restrepo MI; Mortensen EM
J Crit Care; 2016 Dec; 36():265-271. PubMed ID: 27595461
[TBL] [Abstract][Full Text] [Related]
5. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia.
Madaras-Kelly KJ; Remington RE; Fan VS; Sloan KL
J Hosp Med; 2012 Mar; 7(3):195-202. PubMed ID: 22038859
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.
Metersky ML; Frei CR; Mortensen EM
Respirology; 2016 Jan; 21(1):157-63. PubMed ID: 26682638
[TBL] [Abstract][Full Text] [Related]
7. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
[TBL] [Abstract][Full Text] [Related]
9. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
Hyun H; Song JY; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
PLoS One; 2022; 17(6):e0270261. PubMed ID: 35767562
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
11. Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
Jones BE; Ying J; Stevens V; Haroldsen C; He T; Nevers M; Christensen MA; Nelson RE; Stoddard GJ; Sauer BC; Yarbrough PM; Jones MM; Goetz MB; Greene T; Samore MH
JAMA Intern Med; 2020 Apr; 180(4):552-560. PubMed ID: 32065604
[TBL] [Abstract][Full Text] [Related]
12. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia.
Giannella M; Pinilla B; Capdevila JA; Martínez Alarcón J; Muñoz P; López Álvarez J; Bouza E;
Clin Microbiol Infect; 2012 Aug; 18(8):786-94. PubMed ID: 22284436
[TBL] [Abstract][Full Text] [Related]
13. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
14. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.
Chalmers JD; Taylor JK; Singanayagam A; Fleming GB; Akram AR; Mandal P; Choudhury G; Hill AT
Clin Infect Dis; 2011 Jul; 53(2):107-13. PubMed ID: 21690616
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.
Falcone M; Corrao S; Licata G; Serra P; Venditti M
Intern Emerg Med; 2012 Dec; 7(6):523-31. PubMed ID: 22688529
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan.
Wu CL; Ku SC; Yang KY; Fang WF; Tu CY; Chen CW; Hsu KH; Fan WC; Lin MC; Chen W; Ou CY; Yu CJ
J Formos Med Assoc; 2013 Jan; 112(1):31-40. PubMed ID: 23332427
[TBL] [Abstract][Full Text] [Related]
18. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
19. The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.
Jeon EJ; Cho SG; Shin JW; Kim JY; Park IW; Choi BW; Choi JC
Yonsei Med J; 2011 Mar; 52(2):282-7. PubMed ID: 21319347
[TBL] [Abstract][Full Text] [Related]
20. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
Webb BJ; Dascomb K; Stenehjem E; Dean N
Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
